Unilever faces fresh pressure over margins as it backs down on M&A
Unilever (ULVR.L) warned of a big hit to profit margins this year as it struggles to pass on higher costs to consumers, and ruled out major acquisitions after investor criticism of its failed pursuit of GlaxoSmithKline’s consumer health business.
